Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review

References

• Dodd JD, Lavelle LP, Fabre A, et al. Imaging in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med. 2015;36(2):194–206.
   PubMed Web of Science ®Google Scholar
• Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952;7(3):213–239.
   PubMed Web of Science ®Google Scholar
• Kapur N, Masel JP, Watson D, et al. Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: need to redefine bronchial dilatation. Chest. 2011;139(6):1445–1450.
   PubMed Web of Science ®Google Scholar
• Mott L, Graniel K, Park J, et al. Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest. 2013;144:1193–1198.
   PubMed Web of Science ®Google Scholar
• de Jong PA, Tiddens HAWM. Cystic fibrosis–specific computed tomography scoring. Proc Am Thor Soc. 2007;4(4):338–342.
   PubMedGoogle Scholar
• Mott L, Park J, Gangell C, et al. Distribution of early structural lung changes due to cystic fibrosis detected by chest computed tomography. J Pediatr. 2013;163:243–248.
   PubMed Web of Science ®Google Scholar
• Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012;67(6):509–516.
   PubMed Web of Science ®Google Scholar
• Brody AS, Klein JS, Molina PL, et al. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004;145(1):32–38.
   PubMed Web of Science ®Google Scholar
• Calder AD, Bush A, Brody AS, et al. Scoring of chest CT in children with cystic fibrosis: state of the art. Pediatr Radiol. 2014;44(12):1496–1506.
   PubMed Web of Science ®Google Scholar
• Rosenow T, Oudraad MC, Murray CP, et al. PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med. 2015;191(10):1158–1165.
   PubMed Web of Science ®Google Scholar
• Gaillard EA, Carty H, Heaf D, et al. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47(3):215–220.
   PubMed Web of Science ®Google Scholar
• Sly P, Gangell C, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 2013;368:1963–1970.
   PubMed Web of Science ®Google Scholar
• Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med. 2007;175(9):943–950.
   PubMed Web of Science ®Google Scholar
• Loeve M, Krestin GP, Rosenfeld M, et al. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J. 2013;42(3):844–857.
   PubMed Web of Science ®Google Scholar
• Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr. 2009;155(5):623–628.
   PubMed Web of Science ®Google Scholar
• Mott LS, Gangell CL, Murray CP, et al. Bronchiectasis in an asymptomatic infant with cystic fibrosis diagnosed following newborn screening. J Cyst Fibros. 2009;8(4):285–287.
   PubMed Web of Science ®Google Scholar
• Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180(2):146–152.
   PubMed Web of Science ®Google Scholar
• Gangell C, Gard S, Douglas TA, et al. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis. 2011;53(5):425–432.
   PubMed Web of Science ®Google Scholar
• Douglas TA, Brennan S, Berry L, et al. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis. Thorax. 2010;65(11):985–990.
   PubMed Web of Science ®Google Scholar
• Douglas TA, Brennan S, Gard S, et al. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J. 2009;33(2):305–311.
   PubMed Web of Science ®Google Scholar
• Wainwright CE, Vidmar S, Armstrong DS, et al. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. J Am Med Assoc. 2011;306(2):163–171.
   PubMed Web of Science ®Google Scholar
• Thia LP, Calder A, Stocks J, et al. Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age? Thorax. 2014;69(4):320–327.
   PubMed Web of Science ®Google Scholar
• Bush A, Sly PD. Evolution of cystic fibrosis lung function in the early years. Curr Opin Pulm Med. 2015;21(6):602–608.
   PubMed Web of Science ®Google Scholar
• Lapa E Silva JR, Guerreiro D, Noble B, et al. Immunopathology of experimental bronchiectasis. Am J Respir Cell Mol Biol. 1989;1(4):297–304.
   PubMed Web of Science ®Google Scholar
• Regamey N, Tsartsali L, Hilliard TN, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax. 2012;67(2):164–170.
   PubMed Web of Science ®Google Scholar
• Fischer AJ, Singh SB, Adam RJ, et al. Tracheomalacia is associated with lower FEV1 and Pseudomonas acquisition in children with CF. Pediatr Pulmonol. 2014;49(10):960–970.
   PubMed Web of Science ®Google Scholar
• Diwakar A, Adam RJ, Michalski AS, et al. Sonographic evidence of abnormal tracheal cartilage ring structure in cystic fibrosis. Laryngoscope. 2015;125(10):2398–2404.
   PubMed Web of Science ®Google Scholar
• Garratt LW, Sutanto EN, Ling KM, et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Eur Respir J. 2015;46(2):384–394.
   PubMed Web of Science ®Google Scholar
• Ranganathan SC, Parsons F, Gangell C, et al. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax. 2011;66(5):408–413.
   PubMed Web of Science ®Google Scholar
• Byrnes CA, Vidmar S, Cheney JL, et al. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax. 2013;68(7):643–651.
   PubMed Web of Science ®Google Scholar
• Carpio C, Albi G, Rayón-Aledo JC, et al. Changes in structural lung disease in cystic fibrosis children over 4 years as evaluated by high-resolution computed tomography. Eur Radiol. 2015;25(12):3577–3585.
   PubMed Web of Science ®Google Scholar
• Li Z, Sanders DB, Rock MJ, et al. Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol. 2012;47(7):635–640.
   PubMed Web of Science ®Google Scholar
• Awadalla M, Miyawaki S, Alaiwa MHA, et al. Early airway structural changes in cystic fibrosis pigs as a determinant of particle distribution and deposition. Ann Biomed Eng. 2014;42(4):915–927.
   PubMed Web of Science ®Google Scholar
• Bhatt JM. Treatment of pulmonary exacerbations in cystic fibrosis. Eur Respir Rev. 2013;22(129):205–216.
   PubMedGoogle Scholar
• Waters V, Ratjen F. Pulmonary exacerbations in children with cystic fibrosis. Ann Am Thor Soc. 2015;12(Suppl 2):S200–206.
   PubMedGoogle Scholar
• Bortoluzzi CF, Volpi S, D’Orazio C, et al. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection. J Cyst Fibros. 2014;13(5):564–571.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, King L, D’Alessio F. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol. 2014;306:L709–L725.
   PubMed Web of Science ®Google Scholar
• Magon NJ, Turner R, Gearry RB, et al. Oxidation of calprotectin by hypochlorous acid Prevents chelation of essential metal Ions and Allows bacterial growth: relevance to infections in cystic fibrosis. Free Radic Biol Med. 2015;86:133–144.
   PubMed Web of Science ®Google Scholar
• Thomson E, Brennan S, Senthilmohan R, et al. Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. Free Radic Biol Med. 2010;49(9):1354–1360.
   PubMed Web of Science ®Google Scholar
• Goeminne PC, Kiciński M, Vermeulen F, et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143(4):946–954.
   PubMed Web of Science ®Google Scholar
• Knowles MR, Drumm M. The influence of genetics on cystic fibrosis phenotypes. Cold Spring Harb Perspect Med. 2012;2(12):a009548.
   PubMed Web of Science ®Google Scholar
• What is bronchiectasis; 2014 [cited 2016 May 27]. Available from: http://www.nhlbi.nih.gov/health/health-topics/topics/brn
   Google Scholar
• Australian Lung Foundation. Bronchiectasis. 2014 [ updated 2016 Jan 15; [ cited 2016 May 27]. Available from: http://lungfoundation.com.au/wp-content/uploads/2013/12/Bronchiectasis-Sept-2014.pdf
   Google Scholar
• Davies JC, Cunningham S, Harris WT, et al. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med. 2016;4:107–115.
   PubMed Web of Science ®Google Scholar
• Gianotti A, Capurro V, Scudieri P, et al. Pharmacological rescue of mutant CFTR protein improves the viscoelastic properties of CF mucus. J Cyst Fibros. 2016;15:295–301.
   PubMed Web of Science ®Google Scholar
• Graeber SY, Hug MJ, Sommerburg O, et al. Intestinal current measurements detect activation of mutant CFTR in patients with cystic fibrosis with the G551D mutation treated with ivacaftor. Am J Respir Crit Care Med. 2015;192(10):1252–1255.
   PubMed Web of Science ®Google Scholar
• Tsabari R, Elyashar HI, Cymberknowh MC, et al. CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation. J Cyst Fibros. 2015;15:e25–27.
   PubMedGoogle Scholar
• Wainwright CE, Elborn JS, Ramsey BW. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015;373(18):1783–1784.
   PubMed Web of Science ®Google Scholar
• Sheikh SI, Long FR, McCoy KS, et al. Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation. J Cyst Fibros. 2015;14(1):84–89.
   PubMed Web of Science ®Google Scholar
• Henriksen PA. The potential of neutrophil elastase inhibitors as anti-inflammatory therapies. Curr Opin Hematol. 2014;21(1):23–28.
   PubMed Web of Science ®Google Scholar
• Sanders DB, Bittner RC, Rosenfeld M, et al. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182(5):627–632.
   PubMed Web of Science ®Google Scholar
• Tiddens HA, Rosenow T. What did we learn from two decades of chest computed tomography in cystic fibrosis? Pediatr Radiol. 2014;44(12):1490–1495.
   PubMed Web of Science ®Google Scholar
• Ellemunter H, Eder J, Fuchs S, et al. Long-term improvement of lung clearance index in patients with mild cystic fibrosis lung disease: does hypertonic saline play a role? J Cyst Fibros. 2016;15(1):123–126.
   PubMed Web of Science ®Google Scholar
• Hatziagorou E, Avramidou V, Kirvassilis F, et al. Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis. Hippokratia. 2015;19(1):47–52.
   PubMed Web of Science ®Google Scholar
• Ramsey KA, Rosenow T, Turkovic L, et al. Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis. Am J Respir Crit Care Med. 2016;193(1):60–67.
   PubMed Web of Science ®Google Scholar
• Simpson SJ, Ranganathan S, Park J, et al. Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection. Eur Respir J. 2015;46(6):1680–1690.
   PubMed Web of Science ®Google Scholar
• Sonneveld N, Stanojevic S, Amin R, et al. Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations. Eur Respir J. 2015;46(4):1055–1064.
   PubMed Web of Science ®Google Scholar
• Vermeulen F, Proesmans M, Boon M, et al. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax. 2014;69(1):39–45.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Thia LP, Hoo AF, et al. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax. 2014;69(10):910–917.
   PubMed Web of Science ®Google Scholar
• Stahl M, Joachim C, Blessing K, et al. Multiple breath washout is feasible in the clinical setting and detects abnormal lung function in infants and young children with cystic fibrosis. Respiration. 2014;87(5):357–363.
   PubMed Web of Science ®Google Scholar
• Stocks J, Thia LP, Sonnappa S. Evaluation and use of childhood lung function tests in cystic fibrosis. Curr Opin Pulm Med. 2012;18(6):602–608.
   PubMed Web of Science ®Google Scholar
• Subbarao P, Milla C, Aurora P, et al. Multiple-breath washout as a lung function test in cystic fibrosis. A cystic fibrosis foundation workshop report. Ann Am Thor Soc. 2015;12(6):932–939.
   PubMed Web of Science ®Google Scholar
• Tiddens HA, Stick SM, Davis S. Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatr Respir Rev. 2014;15(1):92–97.
   PubMed Web of Science ®Google Scholar
• Wielpütz MO, Mall MA. Imaging modalities in cystic fibrosis: emerging role of MRI. Curr Opin Pulm Med. 2015;21(6):609–616.
   PubMed Web of Science ®Google Scholar
• Ernst CW, Basten IA, Ilsen B, et al. Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels. Radiol. 2014;273(2):597–605.
   PubMed Web of Science ®Google Scholar
• Brady SL, Mirro AE, Moore BM, et al. How to appropriately calculate effective dose for CT using either size-specific dose estimates or dose-length product. AJR Am J Roentgenol. 2015;204(5):953–958.
   PubMed Web of Science ®Google Scholar
• Ciet P, Serra G, Bertolo S, et al. Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT. Eur Radiol. 2016;26:780–787.
   Web of Science ®Google Scholar
• Ciet P, Tiddens HA, Wielopolski PA, et al. Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imaging. Pediatr Radiol. 2015;45(13):1901–1915.
   PubMed Web of Science ®Google Scholar
• Tepper LA, Ciet P, Caudri D, et al. Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort. Pediatr Pulmonol. 2016;51(1):34–41.
   PubMed Web of Science ®Google Scholar
• Wielpütz MO, Puderbach M, Kopp-Schneider A, et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med. 2014;189(8):956–965.
   PubMed Web of Science ®Google Scholar